Huifang Wang

2PUBLICATIONS
26CO-AUTHORS
Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Oct 23, 2025
Targeted degradation of endogenous YAP by nanobody bioPROTAC inhibits tumor progression.

Runhua Zhou, Huifang Wang, Gui-Ming Zhang

|Sep 14, 2020
Nanoparticle-enhanced chemo-immunotherapy to trigger robust antitumor immunity.

Jingjing Liang, Huifang Wang, Wenxiu Ding

Pageof 1

Frequent Collaborators

1 joint publications

Jingjing Liang

1 joint publications

Wenxiu Ding

1 joint publications

Jianxiang Huang

1 joint publications

Xuefei Zhou